JACC This Week · American College of Cardiology

Structural Heart Disease, Obesity-Related Heart Failure, Private Equity Ownership in Hospitals | JACC This Week

·17 min·1 clip

The ACCURATE NEO2 valve failed its trial, leading Boston Scientific to withdraw it globally after 80,000 patients.

This episode of JACC This Week covers key cardiovascular research, including a post-hoc analysis of the ACCURATE NEO2 valve trial linking under-expansion to worse outcomes, insights on obesity-related heart failure and tirzepatide, a study on private equity ownership's impact on heart failure care, and a special communication on multivalvular disease management. It highlights the journal's commitment to advancing heart health through rigorous science and practical implications.

As heard by us

A brisk cardiology issue linking valve trials, central adiposity, and hospital ownership.

Jack This Week moves from valve trials to obesity-related heart failure to private equity ownership in hospitals, and that range gives the issue its shape.

Read the full review in PlayNext →

Why you'd press play

If you want cardiology that connects structural heart disease, obesity-related HFpEF, and care-delivery policy, start here.

Read the full recommendation in PlayNext →

Listen to the show on

Apple Podcasts Spotify

Play clips from this episode More from JACC This Week